Riitta Koivisto-Korander

Author

University of Helsinki ORCID

Also Known As

R. Koivisto-Korander, Riitta Koivisto-Korander, Riitta L. Koivisto-Korander

Publications

641

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital Tampere University Karolinska Institutet

About

Riitta Koivisto-Korander is an author at University of Helsinki specializing in obstetrics, pathology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	353
2	Obstetrics	6	6	353
3	Pathology	6	6	353
4	Surgical Oncology	2	2	98
5	Cell Biology	1	1	134

Riitta Koivisto-Korander

Publications

605

Citations

H-Index

Page 1

	Year	Citations
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12 Netta Mäkinen, Mervi Aavikko, Tuomas Heikkinen, PLoS Genetics Tumor BiologySomatic VariantCancer PathologyMalignant DiseaseUterine Leiomyosarcomas	2016	134
Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001 Riitta Koivisto-Korander, Ralf Bützow, Anna‐Maija Koivisto, Gynecologic Oncology Prognostic FactorsSurgical OncologyGynecological SurgeryMedicinePathology	2008	87
Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: Results from NORDCAN and NOCCA databases Riitta Koivisto-Korander, Jan Ivar Martinsen, Elisabete Weiderpass, Maturitas Uterine FibroidsGynecological SurgeryUterine LeiomyosarcomaGynecologyPathology	2012	74
Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers Riitta Koivisto-Korander, Ralf Bützow, Anna‐Maija Koivisto, Tumor Biology	2010	69
Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness Hanna Karvonen, Mariliina Arjama, Laura Kaleva, Cell Death and Disease	2020	63
Mifepristone as Treatment of Recurrent Progesterone Receptor–Positive Uterine Leiomyosarcoma Riitta Koivisto-Korander, Arto Leminen, Oskari Heikinheimo Obstetrics and Gynecology	2007	30
Molecular characterization in the prediction of disease extent in endometrial carcinoma Anne Kolehmainen, Annukka Pasanen, Riitta Koivisto-Korander, European Journal of Obstetrics & Gynecology and Reproductive Biology Tumor BiologyMolecular CharacterizationMedicineGynecologyPathology	2020	28
Clinical factors as prognostic variables among molecular subgroups of endometrial cancer Anne Kolehmainen, Annukka Pasanen, Taru Tuomi, PLoS ONE	2020	26
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma Astrid Murumägi, Daniela Ungureanu, Suleiman A. Khan, British Journal of Cancer	2022	24
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, Clinical Cancer Research	2023	24

Page 1